Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction
Clinical trial NCT07488689 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07488689
- Sponsor
- University Hospital, Strasbourg, France
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-08-01
- Enrollment
- 568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.